Comparing Treatment Options for Psoriatic Arthritis with Philip Mease, MD
Mease discussed the importance of comparator studies in a growing treatment landscape for PsA.
HCPLive Five at Maui Derm NP+PA Fall 2024
Counting down the most impactful news at major medical meetings, it’s the HCPLive Five! This episode focuses on 5 key updates from Maui Derm NP+PA Fall 2024 in Nashville.
If Successful, Inclisiran Primary Prevention Trial Could Expand Patient Population by More than 22 Million
Rahul Aggarwal, MD, discusses how the VICTORION-1 PREVENT trial eligibility criteria apply to the general US population.
Ashfaq Marghoob, MD: Artificial Intelligence, Smartphone Use for Pigmented Lesion Classification
This segment of Marghoob’s interview featured a discussion of pigmented lesion identification and use of technology such as AI.
Steve Nissen, MD: Optimizing Lp(a) Management by Learning from Missteps with LDL-C
Steve Nissen, MD, discusses how the cardiology community needs to learn from previous mistakes in uptake of LDL-C lowering therapies as it approaches an age of Lp(a)-lowering agents.
Major Diagnostic Challenges for Pigmented Lesions, with Ashfaq Marghoob, MD
In this interview, Marghoob highlights some of the biggest diagnostic challenges faced by dermatologists and other providers when it comes to pigmented lesions.
Christie Ballantyne, MD: 'Exciting' Time for FCS Pipeline
A comparison of the PALISADE and BALANCE trials, with commentary from a leading cardiologist, as the community nears a potential approval in FCS.
Considering Viral Infections in Patients With Rheumatic Disease, with Leonard Calabrese, DO
Calabrese discussed factors for rheumatologists to keep in mind, including recent travel and screening for viral infections.
Advances in Non-Statin Therapies for Dyslipidemia, with Christie Ballantyne, MD
Christie Ballantyne, MD, discusses non-statin therapies, both approved and in development, for managing dyslipidemias from the floor of the 2024 Family Heart Global Summit.
Elliott Elias, MD, MPH: Overcoming Challenges in Prosthetic Valve Evaluation
Elias discusses the challenges of prosthetic valve evaluation, highlighting the role of sonographers, Doppler imaging, and the importance of ongoing training.
The Value of Team-Based Care, Technology in Managing CVD Risk Factors, with Benjamin Scirica, MD
Benjamin Scirica, MD, discusses the importance of team-based care and leveraging technology to optimize the management of cardiovascular risk factors.
Nihar Desai, MD: PROMPT-Lipid and EHR-Based Interventions for Improving Care
Nihar Desai, MD, discusses the results of the PROMPT-Lipid trial while on-site at the 2024 Family Heart Global Summit.
Laurence Sperling, MD: Population Health Approaches to Cardiovascular Disease Prevention
Laurence Sperling, MD, discusses his presentation from the 2024 Family Heart Global Summit examining public health efforts for prevention of cardiovascular disease.
The Role of Virology in Rheumatic Disease, with Leonard Calabrese, DO
Calabrese discussed the multi-faceted role of viral infections in the field of rheumatology ahead of the 2024 CCR West meeting.
Acne and Rosacea Updates 2024, with James Del Rosso, DO
Del Rosso reviews several key highlights from his Maui Derm presentation on acne and rosacea updates from 2024.
Updates on Benzoyl Peroxide Use for Acne, with James Del Rosso, DO
Del Rosso highlights points from his conference talk on benzoyl peroxide (BPO) use among patients with acne and other updates.
Tom C. Nguyen, MD: Evolving Roles of TAVR, SAVR in Aortic Valve Disease
As advancements in valvular technology progress, Nguyen highlights the need for long-term data and multidisciplinary collaboration to improve patient outcomes.
Atypical Clinical Presentations of Blistering Disease, with Donna Culton, MD, PhD
This segment of her interview featured a conversation about the biggest takeaways and notable case series presented in Culton’s talk at Maui Derm NP+PA Fall.
Updates on the Diagnosis of Blistering Diseases, with Donna Culton, MD, PhD
This interview with Culton featured a discussion of key challenges faced when treating patients with blistering diseases such as pemphigus and bullous pemphigoid.
Matthew Zirwas, MD: Discussing Upadacitinib, Other JAK Inhibitors for Atopic Dermatitis
In this segment of his interview, Zirwas highlighted the use of JAK inhibitors such as upadacitinib, discussed safety, and touched on topical options for patients with eczema.
Differentiating Between Different Types of Alopecia, with Jerry Shapiro, MD
Shapiro spoke in his Maui Derm NP+PA Fall conference interview about differentiating between types of alopecia areata and about the potential use of JAK inhibitors.
Most Exciting New Therapies in Atopic Dermatitis, with Matthew Zirwas, MD
Zirwas described several highlights from his presentation on updates in managing atopic dermatitis, describing examples such as lebrikizumab and nemolizumab.
Developing Risk Assessment Tools for Viruses in School
Amanda Wilson, PhD, details how her team is developing risk assessment models to evaluate viral infection intervention in schools.
Julie Harper, MD: Discussing Acne Treatment Updates, Unmet Needs Among Patients
In her Maui Derm NP+PA Fall interview, Harper highlighted treatment approaches and unmet needs of patients with acne.
Using Microbiomes to Diagnose Ventilator-Associated Pneumonia
Georgios Kitsios, MD, PhD, discusses his team's interim results an analysis that is providing insights into the microbiome dynamics of critically ill patients with VAP.
What Do Patients Need to Learn About their Hypersensitivity Pneumonitis?
Kerri Aronson, MD, MS, describes her team's research efforts to create educational resources that address the profound lack of patient knowledge around HP.
What Causes Respiratory Problems in Osteogenesis Imperfecta?
Roy Morello, MD, discusses his team's research into the causes of poor pulmonary function among patients with osteogenesis imperfecta—better known as "brittle bone disease."
Discussing Unmet Needs Among Patients in Dermatology, with Matthew Zirwas, MD
After his review on recent literature, Zirwas’s Maui Derm NP+PA Fall interview featured a discussion about the biggest unmet needs among patients.
Off-Label Treatment Options in Dermatology, with Matthew Zirwas, MD
This interview featured a literature review discussion about non-FDA approved advancements in dermatology, including oral roflumilast for psoriasis, metformin for acne, and minoxidil for nails.
Raj Chovatiya, MD, PhD: Treating Hidradenitis Suppurativa with IL-17, JAK Inhibitors
In this interview segment, Chovatiya highlights HS therapies such as IL-17 inhibitors and JAK inhibitors, as well as unmet needs of patients.